Press-release for stocks publishing date 2022 - 10

Prices are updated after-hours

Motus GI to Release Third Quarter Results and Provide a Business Update on November 14
Published: 2022-10-31 (Crawled : 05:00) - globenewswire.com
MOTS | $0.07 -46.17% 100K

| -96.45% | O: 0.0% H: 16.75% C: 9.64%
update results

| 478.0% | O: -0.4% H: 11.31% C: 8.42%
report financial update results

GT Biopharma Reports Third Quarter Fiscal 2022 Financial Results and Business Update
Published: 2022-10-31 (Crawled : 00:00) - biospace.com/
GTBP | $3.8001 1.3% 5.9K

| 104.64% | O: 0.52% H: 0.0% C: -4.62%
biopharma financial update results

| -47.2% | O: 26.92% H: 3.03% C: -24.24%
ubx1325 macular program trial update diabetic

DBV Technologies to Report Third Quarter 2022 Financial Results and Provide a Business Update
Published: 2022-10-31 (Crawled : 21:00) - globenewswire.com
DBVT | $0.671 1.51% 1.49% 39K

| -56.58% | O: 4.54% H: 0.69% C: -1.2%
report financial update results

ESSA Provides an Update on its Clinical Collaboration with Janssen
Published: 2022-10-31 (Crawled : 17:00) - biospace.com/
EPIX | $6.57 -2.23% -2.28% 100K

| 68.48% | O: -27.44% H: 15.0% C: 12.5%
collaboration update

TRACON to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 14, 2022
Published: 2022-10-31 (Crawled : 17:00) - biospace.com/
TCON | $1.97 -6.64% -7.11% 240K

| 31.06% | O: -0.62% H: 1.87% C: -1.25%
report financial update results

| -20.53% | O: 0.0% H: 18.42% C: 3.16%
pharmaceuticals global brilaroxazine schizophrenia update study

United Health Products Provides Update on FDA PMA Application
Published: 2022-10-31 (Crawled : 13:20) - globenewswire.com
UEEC | $0.2 7.9% 11K

| -36.67% | O: 6.67% H: 3.13% C: -2.38%
fda health application update

Inventiva provides an update on the development of cedirogant by AbbVie
Published: 2022-10-31 (Crawled : 07:00) - inventivapharma.com
IVA | $3.35 -2.9% -2.99% 8.5K

| -44.86% | O: -15.24% H: 0.0% C: -7.47%
update